Rerate vs. Quick Spike, page-5

Actually, I am getting a little concerned about Calimmune. The final data collection point is only a couple of month away and yet there is still no hint of news coming out of the trial. Two of their trials have been suspended/cancelled, including their push into HIV/Oncology. All the recent presentations that they have given use pre-clinical data that is four years old. I would really like to see some sort of interest in the press but, being a private company, I guess they don't need to manipulate announcements in the same way that a public company does.